Skip to content
OpenCapital
Get started

AdaptHealth AHCO Q2 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$819.8MBeat by $23.2M
EPS-$0.06Miss by $0.07
Revenue estimate$796.6M
EPS estimate$0.01

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$846.8M
EPS estimate$0.17

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$1.49B+15.2%
Enterprise value$3.44B+8.4%
P/S0.5×+0.1×

Versus estimates

Revenue

Q2 2026$819.8MBeat by $23.2M
Q4 2025$846.3MBeat by $14.7MQ3 2025$820.3MMiss by $12.2MQ2 2025$800.4MBeat by $1.2MQ1 2025$580.5MMiss by $227.7MQ4 2024$856.6MBeat by $54.4M

Diluted EPS

Q2 2026-$0.06Miss by $0.07
Q4 2025$0.27Miss by $0.07Q3 2025$0.22Miss by $0.02Q2 2025$0.01Miss by $0.14Q1 2025$0.01In lineQ4 2024$0.39Beat by $0.14

Ask the moment AdaptHealth reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did AdaptHealth report Q2 2026 earnings?
AdaptHealth (AHCO) reported Q2 2026 earnings on May 5, 2026 before market open.
What were AdaptHealth's Q2 2026 revenue and EPS?
AdaptHealth reported revenue of $819.8M and eps of $-0.06 for Q2 2026.
Did AdaptHealth beat estimates in Q2 2026?
Revenue beat the consensus estimate of $796.6M by $23.2M. EPS missed the consensus estimate of $0.01 by $0.07.
How did AdaptHealth's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 41.2% from $580.5M a year earlier.
Where can I find AdaptHealth's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-030120) and the 10-Q periodic report (0001628280-26-030602) directly on SEC EDGAR. The filing index links above go to sec.gov.